Measles potential exposure at OKC Will Rogers International Airport, OSDH says

OKLAHOMA CITY (KFOR) – The Oklahoma State Department of Health (OSDH) on Friday confirmed a case of measles at OKC Will Rogers International Airport, creating a potential risk to the public.
According to OSDH officials, an investigation into the potential measles exposure resulted in an individual located in a public setting while contagious.
President Trump's 'One Big Beautiful Bill' raising concerns about future of SNAP benefits and food insecurity
Potential airport measles exposure information is as follows:
Location: OKC Will Rogers International Airport
Address: 710 Terminal Drive, Oklahoma City, OK 73159
Date/Time: 11:15 p.m., May 27, 2025, to 1:30 a.m., May 28, 2025
On Friday, the OSDH posted an updated count of case numbers on their website, with the total count rising to 20 in Oklahoma. Of these, 17 are confirmed, while three are probable.
All 17 confirmed cases are listed as unvaccinated, with two listed as unknown and one listed as vaccinated and having two or more doses.
OSDH says that if an individual visited the location within the date and timeframe and is unvaccinated, unsure of vaccine or immune status, or has concerns, they are encouraged to provide their name and contact information here confidentially.
If additional public setting exposures are identified, they will be immediately posted here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

24 minutes ago

• Yahoo

Canaccord Genuity Keeps Buy Rating on Clover Health (CLOV)

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the 11 Best US Stocks to Invest in Under $5. On April 8, Canaccord Genuity analyst Richard Close reiterated a 'Buy' rating on Clover Health Investments, Corp. (NASDAQ:CLOV) with a price target of $4.50. According to the analyst, the final rate update is good news for Clover Health Investments, Corp. (NASDAQ:CLOV). Close believes this change will help the company and could also improve the managed care sector's overall sentiment. An older Medicare-eligible consumer smiling happily while receiving healthcare services at a clinic. The company is expected to continue growing strongly in 2025. This growth will also help Clover Health Investments, Corp. (NASDAQ:CLOV) in 2026 as the company benefits from reimbursements tied to having a 4-Star rating. Canaccord Genuity will be looking at the competitive landscape closely as new plans for 2026 are introduced. Close noted that the positive rate update should improve the outlook for the managed care sector. Clover Health Investments, Corp. (NASDAQ:CLOV) is an American company that provides Medicare Advantage insurance plans. While we acknowledge the potential of CLOV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

35 minutes ago

• Yahoo

MannKind (MNKD) Presents Pediatric Insulin Trial Data

MannKind Corporation (NASDAQ:MNKD) is one of the 11 Best US Stocks to Invest in Under $5. MannKind Corporation (NASDAQ:MNKD) reported that it will present its inhaled insulin product at the American Diabetes Association's 85th Scientific Sessions, which is taking place from June 20 to June 23 in Chicago. During a 'Future Ready' symposium, Dr. Michael J. Haller, Professor and Chief of Pediatric Endocrinology at the University of Florida, will share results from the randomized period of the INHALE-1 clinical trial. Dr. Haller also serves as the Chair for MannKind Corporation's (NASDAQ:MNKD) Phase 3 INHALE-1 study of Afrezza, an inhaled insulin powder, in children and adolescents between 4 and 17 years old. A close-up of a doctor's hand pressing on an inhaler, conveying the effect of the company's therapeutic products. MannKind Corporation (NASDAQ:MNKD) aims to release the topline results from the full pediatric study with safety extension in the second quarter of 2025. The company also expects to submit a Supplemental Biologics License Application in mid-2025 for a possible pediatric indication for Afrezza. MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company focused on developing and commercializing innovative inhaled therapeutic products and devices for those living with endocrine and orphan lung diseases. While we acknowledge the potential of MNKD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None.

Miami Herald

an hour ago

• Miami Herald

Trump Administration Says Health Insurance Move Will Save $12 Billion

The Centers for Medicare & Medicaid Services (CMS) has announced it is in the final stages of implementing a new rule that it says will 'lower individual health insurance premiums' by 5 percent on average. CMS said the move is expected to save American taxpayers up to $12 billion in 2026, by 'combating the surge of improper enrollments in the Affordable Care Act (ACA) Exchanges.' Concern has been raised by some that these new measures will push many Americans off their health coverage. 'They will indeed save government money, but only by throwing off the ACA rolls millions of individuals who deserve to be on,' Jonathan Gruber, a professor of economics at Massachusetts Institute of Technology, told Newsweek. Newsweek has contacted CMS via email for comment. According to a CMS release, the new rules are being brought in to tackle 'waste, fraud and abuse' in health insurance markets-an issue that is at the forefront of the Trump administration's policies. A Government Accountability Office (GAO) report from 2024 found that $100 billion was discovered in 'improper payments' in 2023 across the Medicare and Medicaid programs. While wasteful spending in health insurance markets has been targeted by the administration to lower the tax burden for Americans, critics are concerned that sweeping cuts and changes will only push many off health coverage, subsequently driving up costs in the long-term. The new regulation, known as the 2025 Marketplace Integrity and Affordability Final Rule, will target 'improper enrollments' in the Affordable Care Act (ACA) Exchanges via a number of measures. It would repeal the monthly special enrollment period (SEP) for individuals with household incomes at or below 150 percent of the federal poverty level, which CMS called was a kind of loophole for unauthorized enrollments. The policy has been 'used by some agents and brokers to improperly enroll ineligible consumers and perform unauthorized plan switching to gain commissions,' CMS said. Income verification will now be required for most new and auto-renewed enrollments receiving premium subsidies to 'ensure people qualify for the premium subsidies they receive,' CMS added. There will also be additional eligibility requirements for the majority of enrollments through SEPs, in order to close 'loopholes that allowed people to wait to enroll until they needed care,' CMS said. In addition, the rule will reduce advanced payments of the premium tax credit (APTC) by $5 a month for auto-renewed plans without eligibility verification. Most of these policy changes are temporary and will expire after the 2026 plan year-they are simply being used as measures to 'immediately tamp down on improper enrollments and the improper flow of federal funds,' according to CMS. Experts have warned about the impact these measures could have on Americans, with Timothy S. Jost, a professor of law at Washington and Lee University telling Newsweek, 'as many as 1.8 million people could lose ACA coverage.' 'This is an addition to the 4.2 million who will lose coverage because the Congress is not extending the enhanced premium tax credits that were adopted during the Biden administration,' he added. Additional actions being made by CMS in regard to ACA Exchanges include a move to ensure federal ACA subsidies will no longer be available 'to help cover the cost of specified sex-trait modification procedures to align an individual's physical appearance or body with an asserted identity that differs from the individual's sex.' Jonathan Gruber, a professor of economics at Massachusetts Institute of Technology, told Newsweek: 'This is classic doublespeak. These actions will throw millions of people off the ACA rolls by setting up arbitrary administrative barriers that make it hard to enroll.' He added: 'There is undoubtably fraud in ACA exchange enrollment. But this is a blunt solution that will remove many deserving enrollees for every undeserving enrollee and lead to hardship for millions.' Timothy S. Jost, a professor of law at Washington and Lee University, told Newsweek: 'The rules that have just been published will dramatically reduce enrollment in the health insurance exchanges by creating barriers to enrollment leaving many people uninsured. The rules are likely to increase premiums rather than reduce them because the added bureaucratic barriers to enrollment will discourage healthy individuals from enrolling and those covered will be much sicker and more costly. To the extent that rules do reduce premiums for some, it will be primarily because the policies they will be buying will be of lower value, with higher deductibles and co-payments and because the premium tax credits they receive will be reduced.' He added: 'The rule may reduce government expenditures, but simply because it reduces the number of Americans covered and the value of their coverage. There has been some fraud by brokers in the federal marketplace but this was already being addressed by excluding fraudulent brokers.' Robert F. Kennedy Jr., U.S. Health and Human Services Secretary, said: 'We are strengthening health insurance markets for American families and protecting taxpayer dollars from waste, fraud, and abuse. With this rule, we're lowering marketplace premiums, expanding coverage for families, and ensuring that illegal aliens do not receive taxpayer-funded health insurance.' Dr. Mehmet Oz, CMS Administrator, said: 'CMS is restoring integrity to ACA Exchanges by cracking down on fraud, protecting American taxpayer dollars, and ensuring coverage is there for those who truly need it. This is about putting patients first, stopping exploitation of the system, and realigning the program with the values of personal responsibility and fiscal discipline.' The finalized policies will apply to plan years 2025 and 2026, after which they are set to expire. Related Articles Aflac Cyber Breach May Expose Customer Health Data, Social Security NumbersMedicare Update: Lawmakers Introduce Bill to Expand Health Care ProgramNew Yorkers Warned of 38 Percent Spike in Health InsuranceMap Shows States Where People Are Being Removed From Health Care Plan 2025 NEWSWEEK DIGITAL LLC.